Sangon Biotech

About:

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

Website: http://www.sangon.com

Top Investors: Qiming Venture Partners, Novo Holdings, CPE, Huagai Capital, GL Capital

Description:

Sangon Biotech Co. (生工生物) is engaged in the research and development of chemical synthesis of DNA. It is a high-tech Sino-foreign joint venture established in 2003. After ten years of development, Sangon has become a professional biotechnology company that integrates research and development. Chemical synthesis DNA earned reputation for Sangon in the global market. In 2006, Sangon invested 50 million to build a manufacturing and industrial base in Songjiang Industrial Park, which has been put into use. Sangon produces various products such as DNA synthesis, DNA sequencing, Gene Synthesis, peptide synthesis, chemical agents, enzymes, molecular biology kit, cultivation medium, lab consumptive material, and miniature instruments.

Total Funding Amount:

$297M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2003-01-01

Contact Email:

sales(AT)sangon.com

Founders:

Qisong Wang

Number of Employees:

1001-5000

Last Funding Date:

2023-04-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai